Floatz logo

Posaconazole

Aspergillosis

Bambino Gesù Hospital and Research InstituteSmall moleculePhase 2/3Active
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Aspergillosis cohort.

Asset / SponsorPhaseRating
Isavuconazole
Astellas Pharma Inc
Phase 3BB
Itraconazole
Rennes University Hospital
Phase 2B
Voriconazole
Rennes University Hospital
Phase 2B
OPELCONAZOLE(INN)
Pulmocide Ltd
Phase 2CCC
Fluconazole
Bochud Pierre-Yves
N/AD

Same molecule, other indications

Posaconazole is also rated in:

acute myeloid leukemiaDormant
BBB
Indicative ·
74 / 100
View asset →
fungal infectious diseaseDormant
BB
Indicative ·
70 / 100
View asset →
neutropeniaDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →